Glenmede Trust’s PRA Health Sciences, Inc. PRAH Stock Holding History

Glenmede Trust’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,942	Closed	-$368K	–	1279
2020 Q4	$368K	Buy	2,942 +2,834	+2,624%	+$317K	﹤0.01%	919
2020 Q3	$10K	Buy	108 +70	+184%	+$7.14K	﹤0.01%	1899
2020 Q2	$3K	Sell	38 -44	-54%	-$4.09K	﹤0.01%	2206
2020 Q1	$9K	Hold	82	–	–	﹤0.01%	2488
2019 Q4	$9K	Sell	82 -185	-69%	-$19K	﹤0.01%	2488
2019 Q3	$26	Sell	267 -4	-1%	-$397	﹤0.01%	1927
2019 Q2	$26	Sell	271 -760	-74%	-$72.5K	﹤0.01%	1959
2019 Q1	$112	Buy	1,031 +777	+306%	+$81.2K	﹤0.01%	1370
2018 Q4	$23	Buy	+254	New	+$25.7K	﹤0.01%	1936
2018 Q3	–	Sell	-200	Closed	-$19K	–	1920
2018 Q2	$19K	Hold	200	–	–	﹤0.01%	1735
2018 Q1	$18K	Hold	200	–	–	﹤0.01%	2008
2017 Q4	$18K	Hold	200	–	–	﹤0.01%	2008
2017 Q3	$15K	Buy	+200	New	+$15.1K	﹤0.01%	2067

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Glenmede Trust's PRAH Position: Q1 2021 in Review

Glenmede Trust sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 2,942 shares — an estimated $368K sold.

Glenmede Trust first reported a position in PRAH in Q3 2017 and held it in 13 quarters. The position peaked at $368K in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

Glenmede Trust reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
Glenmede Trust sold 2,942 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $368K.
Glenmede Trust first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 13 quarters.
Glenmede Trust's PRA Health Sciences, Inc. position peaked at $368K in Q4 2020.
324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.